These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 27998719)
1. The changing face of nanomaterials: Risk assessment challenges along the value chain. Mattsson MO; Simkó M Regul Toxicol Pharmacol; 2017 Mar; 84():105-115. PubMed ID: 27998719 [TBL] [Abstract][Full Text] [Related]
2. Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs. Holsapple MP; Farland WH; Landry TD; Monteiro-Riviere NA; Carter JM; Walker NJ; Thomas KV Toxicol Sci; 2005 Nov; 88(1):12-7. PubMed ID: 16120754 [TBL] [Abstract][Full Text] [Related]
3. [Safety of medicinal nanoproducts: new areas of toxicological research]. Grudziński IP Rocz Panstw Zakl Hig; 2011; 62(3):239-46. PubMed ID: 22171512 [TBL] [Abstract][Full Text] [Related]
4. Nanomaterial health effects--part 1: background and current knowledge. Powell MC; Kanarek MS WMJ; 2006 Mar; 105(2):16-20. PubMed ID: 16628969 [TBL] [Abstract][Full Text] [Related]
5. The hierarchy of environmental health and safety practices in the U.S. nanotechnology workplace. Engeman CD; Baumgartner L; Carr BM; Fish AM; Meyerhofer JD; Satterfield TA; Holden PA; Harthorn BH J Occup Environ Hyg; 2013; 10(9):487-95. PubMed ID: 23927041 [TBL] [Abstract][Full Text] [Related]
6. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. Tsuji JS; Maynard AD; Howard PC; James JT; Lam CW; Warheit DB; Santamaria AB Toxicol Sci; 2006 Jan; 89(1):42-50. PubMed ID: 16177233 [TBL] [Abstract][Full Text] [Related]
7. Nanomaterial health effects--Part 2: Uncertainties and recommendations for the future. Powell MC; Kanarek MS WMJ; 2006 May; 105(3):18-23. PubMed ID: 16749320 [TBL] [Abstract][Full Text] [Related]
8. Risk assessment and risk management of nanomaterials in the workplace: translating research to practice. Kuempel ED; Geraci CL; Schulte PA Ann Occup Hyg; 2012 Jul; 56(5):491-505. PubMed ID: 22752094 [TBL] [Abstract][Full Text] [Related]
9. Nanomaterial health effects part 3: conclusion--hazardous issues and the precautionary principle. Kanarek MS WMJ; 2007 Feb; 106(1):16-9. PubMed ID: 17393752 [TBL] [Abstract][Full Text] [Related]
10. Criteria for grouping of manufactured nanomaterials to facilitate hazard and risk assessment, a systematic review of expert opinions. Landvik NE; Skaug V; Mohr B; Verbeek J; Zienolddiny S Regul Toxicol Pharmacol; 2018 Jun; 95():270-279. PubMed ID: 29614343 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of exposure concentrations used in assessing manufactured nanomaterial environmental hazards: are they relevant? Holden PA; Klaessig F; Turco RF; Priester JH; Rico CM; Avila-Arias H; Mortimer M; Pacpaco K; Gardea-Torresdey JL Environ Sci Technol; 2014 Sep; 48(18):10541-51. PubMed ID: 25158225 [TBL] [Abstract][Full Text] [Related]
13. In silico analysis of nanomaterials hazard and risk. Cohen Y; Rallo R; Liu R; Liu HH Acc Chem Res; 2013 Mar; 46(3):802-12. PubMed ID: 23138971 [TBL] [Abstract][Full Text] [Related]
14. Grouping of nanomaterials to read-across hazard endpoints: from data collection to assessment of the grouping hypothesis by application of chemoinformatic techniques. Lamon L; Asturiol D; Richarz A; Joossens E; Graepel R; Aschberger K; Worth A Part Fibre Toxicol; 2018 Sep; 15(1):37. PubMed ID: 30249272 [TBL] [Abstract][Full Text] [Related]
15. The applicability of chemical alternatives assessment for engineered nanomaterials. Hjorth R; Hansen SF; Jacobs M; Tickner J; Ellenbecker M; Baun A Integr Environ Assess Manag; 2017 Jan; 13(1):177-187. PubMed ID: 26887668 [TBL] [Abstract][Full Text] [Related]
16. Perspectives for integrating human and environmental risk assessment and synergies with socio-economic analysis. Péry AR; Schüürmann G; Ciffroy P; Faust M; Backhaus T; Aicher L; Mombelli E; Tebby C; Cronin MT; Tissot S; Andres S; Brignon JM; Frewer L; Georgiou S; Mattas K; Vergnaud JC; Peijnenburg W; Capri E; Marchis A; Wilks MF Sci Total Environ; 2013 Jul; 456-457():307-16. PubMed ID: 23624004 [TBL] [Abstract][Full Text] [Related]
17. Toxicological aspects for nanomaterial in humans. Dusinska M; Magdolenova Z; Fjellsbø LM Methods Mol Biol; 2013; 948():1-12. PubMed ID: 23070759 [TBL] [Abstract][Full Text] [Related]
18. Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Bouwmeester H; Lynch I; Marvin HJ; Dawson KA; Berges M; Braguer D; Byrne HJ; Casey A; Chambers G; Clift MJ; Elia G; Fernandes TF; Fjellsbø LB; Hatto P; Juillerat L; Klein C; Kreyling WG; Nickel C; Riediker M; Stone V Nanotoxicology; 2011 Mar; 5(1):1-11. PubMed ID: 21417684 [TBL] [Abstract][Full Text] [Related]
20. Health and safety practices in the nanomaterials workplace: results from an international survey. Conti JA; Killpack K; Gerritzen G; Huang L; Mircheva M; Delmas M; Harthorn BH; Appelbaum RP; Holden PA Environ Sci Technol; 2008 May; 42(9):3155-62. PubMed ID: 18522088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]